USPTO serial 99551715
BIOMARKER PROBABILITY FUSION
Status 641Office Action
- Filing date
- Dec 16, 2025
- Status date
- Jul 1, 2026
- Registration date
- —
- Examiner
- DUBIN, DAVID I
Need help with BIOMARKER PROBABILITY FUSION?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: October 1, 2026
Office Action issues
The examiner has identified that your trademark is considered merely descriptive and that you need to clarify the description of your goods in the application.
Owner
PulseLogic Biosciences, Inc.
Uniondale, NY, US
FAR ROCKAWAY VENTURES IP LLC
UNIONDALE, NY, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable medical software for for biomarker analysis, namely, using biomarker, gene expression, and clinical data to generate prognostic and risk-stratification scores, perform gene expression analysis, and support cancer diagnostics and treatment decisions using probability-fusion algorithms. | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Jul 29, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Jul 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Jul 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Apr 20, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Apr 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 16, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Dec 16, 2025 | NWAP | NEW APPLICATION ENTERED |